Wigen Biomedicine Technology (shanghai) Co., Ltd.
Clinical trials sponsored by Wigen Biomedicine Technology (shanghai) Co., Ltd., explained in plain language.
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called WJB001 combined with other cancer treatments for people with advanced solid tumors that have not responded to standard care. The goal is to find safe doses and see if the combinations can shrink tumors. About 86 adults will participa…
Phase: PHASE1, PHASE2 • Sponsor: Wigen Biomedicine Technology (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New pill hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called WJB001 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. About 210 adults will take part in three phases: starting with lo…
Phase: PHASE1, PHASE2 • Sponsor: Wigen Biomedicine Technology (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC